SERious EPI

Do you want to know more about methods in epidemiology but don’t have the time read a bunch of papers on the topic? Do you want to keep current on the latest developments but can’t go back to school for another degree? Do you just want the big picture understanding so you can follow along?

SERious Epi is a podcast from the Society for Epidemiologic Research that I co-host with Dr. Matt Fox from Boston University.

The podcast includes interviews with epidemiologists who are experts on cutting edge and novel methods. In each episode we do a deep dive into a particular method or topic. Our interviews focus on why these methods are so important and how they are currently being used.

The podcast is targeted towards current students and trainees as well as practicing epidemiologists who want to brush up on their epi methods.

For the third season of the SERious Epi podcast, Dr. Matthew Fox and I are going to continue our close-reading of the newest version of the Modern Epidemiology, 4th edition textbook.

S1E1: SERious EPI – Introduction

Do you want to know more about novel methods in epidemiology but don’t have the time read a bunch of papers on the topic? Do you want to keep current on the latest developments but can’t go back to school for another degree? Do you just want the big picture understanding so you can follow along? SERious EPI is a new podcast from the Society for Epidemiologic Research hosted by Hailey Banack and Matt Fox. The podcast will include interviews with leading epidemiology researcher who are experts on cutting edge and novel methods. Interviews will focus on why these methods are so important, what problems they solve, and how they are currently being used. The podcast is targeted towards current students as well as practicing epidemiologists who want to learn more from experts in the field.

S1E2: The Time is Not on Your Side Episode with Dr. Ellie Murray

Have you ever wondered why it is so important to consider the concept of time in epidemiologic analyses? And, more importantly, what strategies exist to appropriately account for time and time-varying variables? Time dependent confounding? In the first-ever episode of SERious Epidemiology, Dr. Eleanor Murray will be discussing the concept of time in epidemiologic research and explaining different types of time-related bias.

After listening to this podcast, if you’re interested in learning more about time or checking out any of the resources mentioned on this podcast, links are included below:

  1. Young, J.G., Vatsa, R., Murray, E.J. et al. Interval-cohort designs and bias in the estimation of per-protocol effects: a simulation study. Trials 20, 552 (2019). Read More
  1. Weuve J, Tchetgen Tchetgen EJ, Glymour MM, et al. Accounting for bias due to selective attrition: the example of smoking and cognitive decline. Epidemiology. 2012;23(1):119-128. Read More
  1. Hernán MA, Robins JM (2020). Causal Inference: What If. Boca Raton: Chapman & Hall/CRC. Read More
  1. Society for Epidemiologic Research 2019 Annual Meeting Symposium Presentation

“The Baddest of the Bad: Ranking the Most Pernicious Biases Facing Observational Studies”

Catherine Lesko, Matthew Fox, Robert Platt, Maria Glymour, Jessie Edwards, Ashley Naimi, Chanelle Howe, Jay Kaufman. Read More

For anyone interested in learning more specifically about immortal time bias, this paper is a terrific introduction:

Lévesque LE, Hanley JA, Kezouh A, Suissa S. Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes. BMJ. 2010;340:b5087. Read More

S1E2.5: “Making Causal Inference More Social and (Social) Epidemiology More Causal” with Dr. Onyebuchi Arah and Dr. John W. Jackson

At SER 2019, the Cassel lecture was delivered by Miguel Hernán and Sandro Galea on the topic of  reconciling social epidemiology and causal inference. Their talk was turned into a paper in the American Journal of Epidemiology, and in March 2020, was published along with a series of responses by Drs. Enrique Schisterman, Whitney Robinson and Zinzi Bailey, Tyler VanderWeele, and John Jackson and Onyebuchi Arah.  In this SERious Epi bonus journal club episode, we had conversation with Dr. John Jackson and Dr. Onyebuchi Arah about their commentary and had the opportunity to ask their thoughts on the other topics published in that issue.

Links:

  • Win-Win: Reconciling Social Epidemiology and Causal Inference by Sandro Galea and Miguel A Hernán
    Read More
  • Editorial: Let’s Be Causally Social by Enrique F Schisterman
    Read More
  • Invited Commentary: What Social Epidemiology Brings to the Table—Reconciling Social Epidemiology and Causal Inference by Whitney R Robinson, Zinzi D Bailey
    Read More
  • Invited Commentary: Counterfactuals in Social Epidemiology—Thinking Outside of “the Box”
    Read More
  • Invited Commentary: Making Causal Inference More Social and (Social) Epidemiology More Causal by John W Jackson and Onyebuchi A Arah
    Read More
  • Galea and Hernán Respond to “Brings to the Table,” “Differential Measurement Error,” and “Causal Inference in Social Epidemiology”
    Read More

S1E3: The Countercultural Counterfactual Episode with Dr. Daniel Westreich

Causal inference and the potential outcomes model are now both commonly taught in graduate programs in epidemiology. However, I think we can all agree that counterfactual thinking can be a bit mind-bending at times and it is really easy to get lost deep in the weeds when trying to think through the potential for unobserved comparison groups or outcomes. In this episode of SERious Epi, we speak to Dr. Daniel Westreich about counterfactuals, the difference between causal inference and causal effect estimation, and assumptions required to estimate causal effects from observational data.

After listening to this podcast, if you’re interested in learning more about the potential outcomes model or checking out any of the resources mentioned on this podcast, links are included below:

– Rose, G. Sick individuals and sick populations. International Journal of Epidemiology 1985; 14:32–38.

– Greenland, S. For and Against Methodologies: Some Perspectives on Recent Causal and Statistical Inference Debates. Eur J Epidemiol 32, 3–20 (2017). Read More

– Morabia, Alfredo. “On the Origin of Hill’s Causal Criteria.” Epidemiology 2, no. 5 (1991): 367-69. Accessed August 13, 2020. Read More.

– Hernán MA, Robins JM (2020). Causal Inference: What If. Boca Raton: Chapman & Hall/CRC.

-Westreich, D. (2020). Epidemiology by Design: A Causal Approach to the Health Sciences. Read More

– Hernán MA, Hernández-Díaz S, Robins JM. A structural approach to selection bias. Epidemiology. 2004;15:615-625.

– Hernán MA, Taubman SL. Does obesity shorten life? The importance of well-defined interventions to answer causal questions. Int J Obes. 2008;32:s8-s14.

-Neyman, J (1923) Read More

– Donald B Rubin (2005) Causal Inference Using Potential Outcomes, Journal of the American Statistical Association, 100:469, 322-331, DOI: Read More

– Edwards JK, Cole SR, Westreich D. All your data are always missing: incorporating bias due to measurement error into the potential outcomes framework. Int J Epidemiol. 2015;44(4):1452-1459. doi:10.1093/ije/dyu272

– Westreich D, Edwards JK, Cole SR, Platt RW, Mumford SL, Schisterman EF. Imputation approaches for potential outcomes in causal inference. Int J Epidemiol. 2015;44(5):1731-1737. doi:10.1093/ije/dyv135

S1E4: Statisticalize your intervention soup: A journal club episode discussing Hernan and Taubman’s “Does obesity shorten life?”

In this journal club episode, we discuss one of our top 10 favourite epidemiology papers: “Does obesity shorten life? The importance of well-defined interventions to answer causal questions” by Miguel Hernán and Sarah Taubman. We talk about the consistency assumption in causal inference, why we think measurement error needs to be added to the list of assumptions for causal inference, and invent a new word (“statisticalize”) to dismiss the notion that fancy methods can always solve our problems.

 

References:

Hernán MA, Taubman SL. Does obesity shorten life? The importance of well-defined interventions to answer causal questions. Int J Obes. 2008;32:s8-s14.

Cole S, Frangakis C. The consistency statement in causal inference: a definition or an assumption? Epidemiology. 2009; 20:3-5.

S1E5: Putting the Social Back in Social Epidemiology with Dr. Whitney Robinson

Is all epidemiology social epidemiology? If I am someone who studies cancer, or obesity, or infectious disease, or any other branch of epidemiology, should I be considering topics related to social epidemiology in my own work? In this episode of SERious Epidemiology, Dr. Whitney Robinson joins us to explain key concepts in social epidemiology.

After listening to this podcast, if you are interested in learning more about social epidemiology or some of the resources mentioned are included below:

  1. Kaufman, J.S. & Oakes, M. Methods in Social Epidemiology, 2nd edition. Read More
  1. Link, Bruce G., and Jo Phelan. “Social Conditions As Fundamental Causes of Disease.” Journal of Health and Social Behavior, 1995, pp. 80–94. JSTOR, Read More.
  2. Chandra Ford’s work on critical race praxis:

Ford, Chandra L, and Collins O Airhihenbuwa. “Critical Race Theory, race equity, and public health: toward antiracism praxis.” American journal of public health vol. 100 Suppl 1,Suppl 1 (2010): S30-5. doi:10.2105/AJPH.2009.171058

Ford CL, Airhihenbuwa CO. The public health critical race methodology: Praxis for antiracism research. Social Science & Medicine. 2010;71:1390-1398.

  1. VanderWeele TJ, Robinson WR. On the causal interpretation of race in regressions adjusting for confounding and mediating variables. Epidemiology. 2014;25(4):473-484. doi: 10.1097/ EDE.0000000000000105
  2. VanderWeele TJ, Robinson WR. Rejoinder: how to reduce racial disparities?: Upon what to intervene?. Epidemiology. 2014;25(4):491-493. doi: 10.1097/ EDE.0000000000000124
  3. Whitney R Robinson, Zinzi D Bailey, Invited Commentary: What Social Epidemiology Brings to the Table—Reconciling Social Epidemiology and Causal Inference, American Journal of Epidemiology, Volume 189, Issue 3, March 2020, Pages 171–174, Read More

S1E6: Questioning the Questions with Maria Glymour

Why is it so important to ask good study questions? Why is it so hard to develop good study questions? Do all study questions need to be directly relevant for public health policy?  In this episode of SERious Epidemiology, we talk with Dr. Maria Glymour about what it means to ask a good study question and how we can get better at asking questions that will make a meaningful contribution to public health.

After listening to this podcast, if you’re interested in learning more about some of the topics we discussed, here are links for you to check out:

  1. David U. Himmelstein, Robert M. Lawless, Deborah Thorne, Pamela Foohey, and Steffie Woolhandler, 2019. Medical Bankruptcy: Still Common Despite the Affordable Care Act American Journal of Public Health 109, 431_433. Read More
  1. Hernán MA, Alonso A, Logan R, et al. Observational studies analyzed like randomized experiments: an application to postmenopausal hormone therapy and coronary heart disease. Epidemiology. 2008;19(6):766-779. Read More
  1. Maria Glymour and Rita Hamad, 2018. Causal Thinking as a Critical Tool for Eliminating Social Inequalities in Health. American Journal of Public Health 108, 623_623. Read More
  1. Harper S, Strumpf EC. Social epidemiology: questionable answers and answerable questions. Epidemiology. 2012 Nov;23(6):795-8. doi: 10.1097/ EDE.0b013e31826d078d.
  1. Sandro Galea, An Argument for a Consequentialist Epidemiology, American Journal of Epidemiology, Volume 178, Issue 8, 15 October 2013, Pages 1185–1191. Read More

S1E7: The Bread and Butter of Bayes with Ghassan Hamra

In this episode we interview Dr. Ghassan Hamra and talk about all things Bayesian. If you’re like us, you have likely been trained in traditional, frequentist approaches to statistics and have always wondered what the big deal is about Bayesian approaches. Well, have no fear, Dr. Hamra is here to explain it all. In this episode we cover a range of topics introducing Bayesian analyses, including how Bayesian and frequentist statistics differ, the concept of integrating a prior into your analyses, and whether Bayesian statistics are really a “subjective” approach (**spoiler alert: they’re not).

After listening to this podcast, if you’re interested in learning more about Bayesian analyses some links are included below:

  1. MacLehose, R.F., Hamra, G.B. Applications of Bayesian Methods to Epidemiologic Research. Curr Epidemiol Rep 1, 103–109 (2014). Read More
  1. Hamra GB, MacLehose RF, Cole SR. Sensitivity analyses for sparse-data problems-using weakly informative bayesian priors. Epidemiology. 2013;24(2):233-239. doi: 10.1097/ EDE.0b013e318280db1d
  1. Website with links to Dr. Hamra’s publications and presentations/tutorials: Publications Presentations
  1. Series of articles by Sander Greenland on Bayesian methods for epidemiology:

Sander Greenland, Bayesian perspectives for epidemiological research: I. Foundations and basic methods, International Journal of Epidemiology, Volume 35, Issue 3, June 2006, Pages 765–775, Read More

Sander Greenland, Bayesian perspectives for epidemiological research. II. Regression analysis, International Journal of Epidemiology, Volume 36, Issue 1, February 2007, Pages 195–202, Read More

Sander Greenland, Bayesian perspectives for epidemiologic research: III. Bias analysis via missing-data methods, International Journal of Epidemiology, Volume 38, Issue 6, December 2009, Pages 1662–1673, Read More

  1. MacLehose RF, Gustafson P. Is probabilistic bias analysis approximately Bayesian?. Epidemiology. 2012;23(1):151-158. doi: 10.1097/ EDE.0b013e31823b539c

S1E8: The Discipline Olympics: Epidemiology vs. Public Health with Dr. Laura Rosella

Given the COVID-19 pandemic there is an urgent need for us to better understand how scientific evidence generated in epidemiologic research gets translated into information that can be used to create public health policy. In this episode of SERious Epidemiology, we talk with Dr. Laura Rosella about data driven public health, the role of epidemiology in public health, and more broadly, the importance of knowledge translation for epidemiologists.

After listening to this podcast, if you are interested in learning more about the intersection of epidemiology and public health some resources are included below:

  1. How’s my flattening: A centralized data analytics and visualization hub monitoring Ontario’s response to COVID-19
    Link: howsmyflattening.ca
  1. Definitions of epidemiology, including references to the definition Dr. Rosella mentioned from McMahon and Pugh’s epidemiology textbook (1970):
    Frérot M, Lefebvre A, Aho S, Callier P, Astruc K, Aho Glélé LS. What is epidemiology? Changing definitions of epidemiology 1978-2017. PLoS One. 2018;13(12): e0208442. doi: 10.1371/ journal.pone.0208442

    Terris, M. Approaches to an Epidemiology of Health. Am J Public Health. 1975; 65(10)
    Read More

  1. The use of scientific evidence for public health decision making:
    Rosella LC, Wilson K, Crowcroft NS, Chu A, Upshur R, Willison D, Deeks SL, Schwartz B, Tustin J, Sider D, Goel V. Pandemic H1N1 in Canada and the use of evidence in developing public health policies–a policy analysis. Soc Sci Med. 2013 Apr;83:1-9.
    doi: 10.1016/ j.socscimed.2013.02.009.
  1. Agent-based modeling
    Tracy M, Cerdá M, Keyes KM. Agent-Based Modeling in Public Health: Current Applications and Future Directions. Annu Rev Public Health. 2018 Apr 1;39:77-94.
    doi: 10.1146/ annurev-publhealth-040617-014317.

Additional info on agent-based modeling:
Read More

S1E9: When Epidemiologists and Variables Collide: with Elizabeth Rose Mayeda

In most introductory epidemiology courses, students are taught about three categories of bias: confounding, information bias, and selection bias. On this episode of the podcast, we talk to Dr. Elizabeth Rose Mayeda about where collider stratification bias fits in to the framework of biases in epidemiology. Is collider stratification bias the same as selection bias? Why is collider bias so hard to understand, conceptually and empirically? Does collider stratification bias even matter? Listen in for some great conversation explaining these topics and others.

After listening to this podcast, if you are interested in learning more about selection bias and collider stratification bias some resources are included below:

Hernán MA, Hernández-Díaz S, Robins JM. A structural approach to selection bias. Epidemiology. 2004;15:615-625.

Howe CJ, Cole SR, Lau B, Napravnik S, Eron JJJ. Selection Bias Due to Loss to Follow Up in Cohort Studies. Epidemiology. 2016;27:91-97.

Hernán MA. Invited Commentary: Selection Bias Without Colliders. American journal of epidemiology. 2017;185:1048-1050.

Greenland S. Response and follow-up bias in cohort studies. Am J Epidemiol. 1977 Sep;106(3):184-7. doi: 10.1093/ oxfordjournals.aje.a112451.

Kleinbaum D, Morgenstern H, Kupper L. Selection bias in epidemiologic studies. Am J Epidemiol. 1981;113:452-463.

Greenland S, Pearl J, Robins JM. Causal Diagrams for Epidemiologic Research. Epidemiology. 1999;10:37-48.

Mayeda ER, Banack HR, Bibbins-Domingo K, Zeki Al Hazzouri A, Marden JR, Whitmer RA, et al. Can Survival Bias Explain the Age Attenuation of Racial Inequalities in Stroke Incidence?: A Simulation Study. Epidemiology. 2018;29:525-532.

S1E10: Quasi-experimental Studies – A Love Story: With Tarik Benmarhnia

What puts the quasi in quasi-experimental designs? What makes a quasi-experimental study different than a “real” experiment? Ever wondered about the difference between regression discontinuity, difference-in-differences, and synthetic control methods? Dr. Tarik Benmarnhia joins us on this episode of SERious Epidemiology to talk us through a range of quasi-experimental designs. He makes a strong case for why we should integrate these designs in a variety of settings in epidemiology ranging from public health policy to clinical epidemiology

After listening to this podcast, if you are interested in learning more about quasi-experimental designs, you can check out some of the resources below:

Abadie A, Diamond A, Hainmueller J. (2010) Synthetic Control Methods for Comparative Case Studies: Estimating the Effect of California’s Tobacco Control Program, Journal of the American Statistical Association, 105:490, 493-505, DOI: 10.1198/jasa.2009.ap08746

Chen H, Li Q, Kaufman JS, Wang J, Copes R, Su Y, Benmarhnia T. Effect of air quality alerts on human health: a regression discontinuity analysis in Toronto, Canada. Lancet Planet Health. 2018 Jan;2(1):e19-e26. doi: 10.1016/S2542-5196(17)30185-7. Epub 2018 Jan 9. PMID: 29615204.

Auger N, Kuehne E, Goneau M, Daniel M. Preterm birth during an extreme weather event in Québec, Canada: a “natural experiment”. Matern Child Health J. 2011 Oct;15(7):1088-96. doi: 10.1007/s10995-010-0645-0. PMID: 20640493.

Hernán MA, Robins JM. Instruments for causal inference: an epidemiologist’s dream? Epidemiology. 2006 Jul;17(4):360-72. doi: 10.1097/ 01.ede.0000222409.00878.37. Erratum in: Epidemiology. 2014 Jan;25(1):164. PMID: 16755261.

Courtemanche, C., Marton, J., Ukert, B., Yelowitz, A. and Zapata, D. (2017), Early Impacts of the Affordable Care Act on Health Insurance Coverage in Medicaid Expansion and Non‐Expansion States. J. Pol. Anal. Manage., 36: 178-210. Read More

Bor J, Fox MP, Rosen S, Venkataramani A, Tanser F, Pillay D, Bärnighausen T. Treatment eligibility and retention in clinical HIV care: A regression discontinuity study in South Africa. PLoS Med. 2017 Nov 28;14(11):e1002463. doi: 10.1371/journal.pmed.1002463. PMID: 29182641; PMCID: PMC5705070.

Bor J, Moscoe E, Mutevedzi P, Newell ML, Bärnighausen T. Regression discontinuity designs in epidemiology: causal inference without randomized trials. Epidemiology. 2014 Sep;25(5):729-37. doi: 10.1097/EDE.0000000000000138. PMID: 25061922; PMCID: PMC4162343.

Elder TE. The importance of relative standards in ADHD diagnoses: evidence based on exact birth dates. J Health Econ. 2010;29(5):641-656. doi:10.1016/j.jhealeco.2010.06.003

Smith LM, Kaufman JS, Strumpf EC, Lévesque LE. Effect of human papillomavirus (HPV) vaccination on clinical indicators of sexual behaviour among adolescent girls: the Ontario Grade 8 HPV Vaccine Cohort Study. CMAJ. 2015;187(2):E74-E81. doi:10.1503/cmaj.140900

S1E11: The need for theory in epidemiology – with Dr. Nancy Krieger

This episode features an interview with Dr. Nancy Krieger, Professor of Social Epidemiology at the T.H. Chan School of Public Health and author of Epidemiology and the People’s Health: Theory and Context. Dr. Krieger discusses the importance of using conceptual frameworks to improve people’s health and the role of population-level determinants of health (including social determinants) in population health research.  We discuss a range of topics, including the differences between biomedical and analytics driven approaches to population health research and theory driven research, as well as the importance of descriptive epidemiology.

S1E12: Epidemiology podcast crossover

In honor of the Society for Epidemiologic Research 2020 Meeting, the hosts of four epidemiology podcasts came together to record the first ever “crossover event” to talk about their experiences recording our shows and what podcasting can bring to the table for the field of epidemiology. Join the hosts of Epidemiology Counts (Bryan James), SERiousEPi (Matt Fox, Hailey Banack), Casual Inference (Lucy D’Agostino McGowan), and Shiny Epi People (Lisa Bodnar) as they engage in a fun and informative (we hope!) conversation of the burgeoning field of epidemiology podcasting, emceed by Geetika Kalloo. The audio podcast will be released on some of our pod feeds, and the video recording will be available to watch on the SER website.

S1E13: It’s all about the instruments: with Sonja Swanson

What are instrumental variables? Should I be using them in my research? And if so, how do I do that? In this episode of SERious Epidemiology, we talk with Dr. Sonja Swanson about what instrumental variables are and what’s so great (and not so great) about them.

After listening to this podcast, if you’re interested in learning more about some of the topics we discussed, here are links for you to check out:

  1. Greenland S. An introduction to instrumental variables for epidemiologists. Int J Epidemiol. 2018;47(1):358.
  2. Swanson SA, Labrecque J, Hernán MA. Causal null hypotheses of sustained treatment strategies: What can be tested with an instrumental variable? Eur J Epidemiol. 2018;33(8):723-728.
  3. Brookhart MA, Wang PS, Solomon DH, Schneeweiss S. Instrumental variable analysis of secondary pharmacoepidemiologic data. Epidemiology. 2006;17(4):373-4.
  4. Hernán MA, Robins JM. Instruments for causal inference: an epidemiologist’s dream? Epidemiology. 2006;17(4):360-72.
  5. Swanson SA, Hernán MA. Commentary: how to report instrumental variable analyses (suggestions welcome). Epidemiology. 2013;24(3):370-4.

S1E14: It’s always a competition: Competing Risks with Dr. Bryan Lau

Do you, like us, understand that competing risks are important to account for and yet are not 100% sure exactly what they are and when they matter? Do you stay up at night wondering if competing risks regressions are necessary for valid inference in your study? If so, this episode is for you. Dr. Bryan Lau gives us the details on this important method.

After listening to this podcast, if you’re interested in learning more about some of the topics we discussed, here are links for you to check out:

  1. Koller MT, Raatz H, Steyerberg EW, Wolbers M. Competing risks and the clinical community: irrelevance or ignorance? Stat Med. 2012 May 20;31(11-12):1089-97.
  2. Andersen PK, Geskus RB, de Witte T, Putter H. Competing risks in epidemiology: possibilities and pitfalls. Int J Epidemiol. 2012 Jun;41(3):861-70.
  3. Allignol A, Schumacher M, Wanner C, Drechsler C, Beyersmann J. Understanding competing risks: a simulation point of view. BMC Med Res Methodol. 2011 Jun 3;11:86.
  4. Grambauer N, Schumacher M, Dettenkofer M, Beyersmann J. Incidence densities in a competing events analysis. Am J Epidemiol. 2010 Nov 1;172(9):1077-84.
  5. Lau B, Cole SR, Gange SJ. Competing risk regression models for epidemiologic data. Am J Epidemiol. 2009 Jul 15;170(2):244-56.

S1E15: The pool is big enough for all of us: Representativeness with Dr. Jonathan Jackson

Perhaps the biggest challenge we all face in epidemiologic research is recruitment of study participants. And recruiting a diverse population for our studies that allows for broad generalizability and transportability of effect estimates is something we haven’t done a good enough job of and as a consequence, our work has suffered. While we may think of this as not a methods issue, Dr. Jonathan Jackson helps us understand why representativeness affects or work and how we can do better.

S1E16: Finding the Perfect Match Requires Common Support: Matching with Dr. Anusha Vable

Matching is something we learn about in our intro to epidemiology classes and yet we probably spend little time thinking about it after that, we just do it. But when should we match and when does it help us and when does it hurt us? What do we need to consider before we match? Dr. Anusha Vable joins us to help us understand matching in detail.

For those of you looking to do more reading around matching see:

  • Ho, D., Imai, K., King, G., & Stuart, E. (2007). Matching as Nonparametric Preprocessing for Reducing Model Dependence in Parametric Causal Inference. Political Analysis, 15(3), 199-236. doi:10.1093/pan/mpl013
  • Stuart EA. Matching methods for causal inference: A review and a look forward. Stat Sci. 2010 Feb 1;25(1):1-21. doi: 10.1214/09-STS313. PMID: 20871802; PMCID: PMC2943670.
  • Vable AM, Kiang MV, Glymour MM, Rigdon J, Drabo EF, Basu S. Performance of Matching Methods as Compared With Unmatched Ordinary Least Squares Regression Under Constant Effects. Am J Epidemiol. 2019 Jul 1;188(7):1345-1354. doi: 10.1093/aje/kwz093. PMID: 30995301; PMCID: PMC6601529.
  • Iacus, S., King, G., & Porro, G. (2012). Causal Inference without Balance Checking: Coarsened Exact Matching. Political Analysis, 20(1), 1-24. doi:10.1093/pan/mpr013

S1E17: Do external validity and transportability confuse the daylights out of you?

Ask yourself these true or false questions:

  1. Generalizability and transportability and external validity are all the same thing
  2. Generalizability is a secondary concern to internal validity
  3. We spend too much time in epi training programs teaching internal validity and not enough teaching external validity
  4. Worrying about external validity is largely and academic exercise that doesn’t really have much in the way of real-world impact.

In this episode of SERious Epi we discuss these questions and more with Dr. Megha Mehrotra. While internal and external validity are familiar to nearly all epidemiologists, the concept of transportability is less familiar. Listen in to this episode for a clear description of how concepts related to validity, generalizability, and transportability are similar, and different, from each other.

S1E18: Lifecourse epidemiology: a melting pot of bias?

The topic of this episode is lifecourse epidemiology, defined by Dr. Paola Gilsanz as the biological, behavioural and social processes that influence an individual’s health outcomes throughout their life. Join us as we discuss models commonly used in lifecourse epidemiology, such as the early life critical period model, accumulation model, and pathway model. Is lifecourse epidemiology different than social epidemiology? Is all epidemiology lifecourse epidemiology because we study individuals at some point in their lifetime? Dr. Gilsanz answers these questions for us and also highlights the importance of using different data sources depending on your question of interest and the specific types of bias that are particularly prevalent in lifecourse epidemiology.

Show notes:
Brazilian cheese bread recipe:
Read More

S1E19: SERious Epi Journal Club – BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting

In this journal club episode, Dr. Matt Fox and Dr. Hailey Banack discuss a paper recently published in the New England Journal of Medicine by Dagan et al. on the Pfizer COVID-19 vaccine. Listen in for a real-world example of the concept of emulating a target trial and a discussion of how an epidemiologic study can be described as truly beautiful.

Reference:
Dagan N, Barda N, Kepten E, Miron O, Perchik S, Katz MA, Hernán MA, Lipsitch M, Reis B, Balicer RD. BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting. N Engl J Med. 2021 Feb 24:NEJMoa2101765. doi: 10.1056/NEJMoa2101765. Epub ahead of print. PMID: 33626250; PMCID: PMC7944975.

S1E20: Season 1 Finale: Will we ever have to stop wearing sweatpants to work? Lessons from a year of pandemic podcasting.

Join Matt Fox and Hailey Banack for our final episode of the first season of SERious Epidemiology, a season which happened to take place entirely during the COVID-19 pandemic. The pandemic has raised countless public health issues for us all to consider from virus testing to health disparities to safe classrooms to vaccine distribution. For the first time (maybe ever), nearly everyone knows what epidemiology is, and we are all hopefully done with having to explain that we are not a group of skin doctors (“we study epidemics… not the epidermis”). In this episode we discuss a few pandemic-related issues particularly relevant for epidemiologists, such as whether we’ll ever have to wear work pants again, the use pre-prints and the value of peer review, and issues related to confirmation bias.

S2E1: Modern Epidemiology: An Interview With Dr. Kenneth Rothman​

We are going in a new direction for Season 2 of SERious Epidemiology. This season Hailey and Matt are focusing exclusively on the new fourth edition of the textbook Modern Epidemiology. The textbook has played such an important role in the training of epidemiologists since the first edition was released and has taken on an even larger role within the field as more editions have come out. We will work through each chapter and talk about what key insights we got from them and we will talk to guests about their experiences with the text. In this first episode of the season, we are delighted to present our interview with Dr. Kenneth Rothman, author of the first edition and co-author of editions two through four.

Show notes:
Link to Modern Epidemiology

Link to Epidemiology: An Introduction

S2E2: A discussion on causal inference and scientific reasoning

In this episode of Season 2 of SERious Epidemiology, Hailey and Matt take on Chapters 2 and 3 of Modern Epidemiology… at least that was the plan, we really only got to chapter 2 so we’ll be back again in our next episode for Chapter 3. But in this episode we focused on some key insights around replicability and reproducibility. And camp color wars. You’ll have to listen to understand.

S2E3: More on causal inference and scientific reasoning

In this episode of Season 2 of SERious Epidemiology, Hailey and Matt try to finish off Chapter 3 of Modern Epidemiology given they couldn’t get it all into one episode as originally promised. We talked about potential outcomes, sufficient causes models and DAGs (very hard to do in audio only). We focus on the assumptions for causal inference. And we make a pitch for a Modern Epidemiology Audio Book…read by James Earl Jones.

S2E4: More on causal inference with Dr. Jay Kaufman

In this episode of Season 2 of SERious Epidemiology, Hailey and Matt go back to Chapters 2 and 3 of Modern Epidemiology but this time with guest Dr. Jay Kaufman of McGill University. We focused on the causal inference revolution and how our thinking on some of the issues in the chapter have changed over time as we learn more about these topics.

S2E5: Chapter 4 – The great open vs closed population debate

In this episode of Season 2 of SERious Epidemiology, Hailey and Matt dig into chapter 4 of Modern Epidemiology. We focused on the some of the basic building blocks of epidemiology, rates, proportions and prevalence. We found lots to discuss about defining and open and closed populations and the differences (or similarities?) between populations and cohorts. And we debate whether or not this is the “eat your vegetables” chapter. And Matt displays his ignorance of Olympic sports.

S2E6: Chapter 4 – The building blocks of epi with Dr. Liz Stuart

In this episode of Season 2 of SERious Epidemiology, Hailey and Matt go back to chapter 4 of Modern Epidemiology but this time with Dr. Liz Stuart (who may not have trained as an epidemiologist but definitely thinks like an epidemiologist) who has so many insights on what seem like simple concepts. We also get into some of the differences in the way biostatisticians and epidemiologist think about these ideas. And she helps us with some of the disagreements Hailey and I had in the previous episode.

S2E7: The donut episode: Measures of association

In this episode of Season 2 of SERious Epidemiology, Hailey and Matt record, then re-record due to a technical error (ooops!) a discussion on Chapter 5 on measures of association and measures of effect. We say whether we prefer risks or rates. We talk about the counterfactual, causal contrasts, valid inferences and good comparison groups. We use the phrase “living your best epi life”. And we define the difference between associations and effects. We answer whether smoking cessation programs increase the risk of being hit by a drunk driver (and if so, whether that’s causal). There is a mystery related to a mysterious death in the desert. Matt explains why he almost dropped out of intro epi. Oh and if you are wondering why this is the donut episode, Hailey sent Matt donuts after this episode after realizing (60 minutes in….) that she never pressed ‘record’ and Matt’s wife almost sent them back thinking it was a mistake since she had no idea who they were for.

In the episode we mention two papers:

Identifiability, exchangeability, and epidemiological confounding

S Greenland, JM Robins

International journal of epidemiology 15 (3), 413-419

And

Confounding in health research

S Greenland, H Morgenstern

Annual review of public health 22 (1), 189-212

S2E8: Measures of Effect with Katie Lesko

In this episode of Season 2 of SERious Epidemiology, Hailey and Matt connect with Dr. Katie Lesko for a discussion on Chapter 5 on measures of association and measures of effect. We confess our challenge with working with person time. We talk about the importance of a well specified time zero. We talk about why epidemiology is complicated by free will. We ponder what the counterfactual model looks like with time to event models. We talk about the challenges of real world data vs idealized studies. We discuss the challenges of interpreting effect measure modification. And we learn that Katie was a rower in college and is concerned that her daughter may never win an Olympic medal in gymnastics.

A few papers that are mentioned in the episode:

Hernán MA. Invited Commentary: Selection Bias Without Colliders. Am J Epidemiol. 2017 Jun 1;185(11):1048-1050. doi: 10.1093/aje/kwx077. PMID: 28535177; PMCID: PMC6664806.

Edwards JK, Cole SR, Westreich D. All your data are always missing: incorporating bias due to measurement error into the potential outcomes framework. Int J Epidemiol. 2015 Aug;44(4):1452-9. doi: 10.1093/ije/dyu272. Epub 2015 Apr 28. PMID: 25921223; PMCID: PMC4723683.

Cole SR, Hudgens MG, Brookhart MA, Westreich D. Risk. Am J Epidemiol. 2015 Feb 15;181(4):246-50. doi: 10.1093/aje/kwv001. Epub 2015 Feb 5. PMID: 25660080; PMCID: PMC4325680.

S2E9: The Cohort Studies Brouhaha

In this episode of Season 2 of SERious Epidemiology, Hailey and Matt get into cohort studies. We spend a lot of time confessing our limitations, both personally, and as a field, in assigning person time. We talk about the end of the large cohort study and the challenges in determining when to consider a person as exposed. We talk about issues of immortal person time and whether it is technically acceptable to include those who already have the outcome in a cohort study.

S2E10: The Return of the Cohort Studies

In this episode of Season 2 of SERious Epidemiology, Hailey and Matt get some real world experience with cohort studies in a conversation with Dr. Vasan Ramachandran, PI of the Framingham Heart Study (FHS). FHS is a very well-known cohort study and the model that many of us have in mind when we think of cohort studies. We get a bit of history on FHS and Hailey and I have a chance to ask the questions we have struggled with around cohort studies including the role of representativeness. And, spoiler alert, we learn that FHS did not invent the term “risk factor” as Matt has been telling his students for years.

S2E11: Case Control Studies

In this episode of Season 2 of SERious Epidemiology, Hailey and Matt get into the humble case control study. We discuss the ins and outs of this much maligned study design that has so flummoxed so many in epidemiology. We ask the hard questions about the best way sample in a case control study, whether we spend too much or not enough time on it in our teaching, whether a case control study always has to be nested within some hypothetical cohort, whether the design is inherently more biased than cohort studies (spoiler: no, but…), why some people refer to cases and controls when they are not referring to a case control study, and, if it were on a famous TV show, which character the case control study would be (and more importantly, why Hailey has never seen said TV show).

Papers referenced in this episode:

Selection of Controls in Case-Control Studies: I. Principles
Sholom Wacholder, Joseph K. McLaughlin, Debra T. Silverman, Jack S. Mandel
American Journal of Epidemiology, Volume 135, Issue 9, 1 May 1992, Pages 1019–1028, Read More

Selection of Controls in Case-Control Studies: II. Types of Controls
Sholom Wacholder, Debra T. Silverman, Joseph K. McLaughlin, Jack S. Mandel
American Journal of Epidemiology, Volume 135, Issue 9, 1 May 1992, Pages 1029–1041, Read More

Selection of controls in case-control studies. III. Design options
S Wacholder 1D T SilvermanJ K McLaughlinJ S Mandel
Wacholder S, Silverman DT, McLaughlin JK, Mandel JS. Selection of controls in case-control studies. III. Design options. Am J Epidemiol. 1992 May 1;135(9):1042-50.
doi: 10.1093/ oxfordjournals.aje.a116398

S2E12: How great are case-control studies with Ellie Matthay

In this episode of Season 2 of SERious Epidemiology, (recorded back when we were getting COVID booster shots) Hailey and Matt connect with Dr. Ellie Matthay for a discussion on Chapter 8 on case-control studies. We finally answer whether it is spelled with a – or not (and Hailey and Ellie disagree with Matt about semicolons). We discuss how cohort studies and case control studies differ and overlap. We talk about whether case control studies are more biased than cohort studies. And Hailey reveals her dreams for releasing Modern Epidemiology: the Audiobook (with possible singing).

S2E13: Confounding: Ten thousand arrows going into a bunch of squiggly things

In this episode of Season 2 of SERious Epidemiology, Hailey and Matt discuss confounding and whether confounding is hogging the spotlight in epi methods and epi teaching. We debate the value of all the different terms for confounding in the world of epi and beyond and struggle to define them all. We talk about different definitions for confounding and we differentiate between confounders and confounding. We talk about the 10% change in estimate of effect approach and its limitations and we talk about different strategies for confounder control. And Hailey coins the term “DAGmatist”.

We reference the paper below:

VanderWeele, T.J. and Shpitser, I. (2011). A new criterion for confounder selectionBiometrics, 67:1406-1413.

S2E14: Confounding will never go away – with Maya Mathur

In this episode of Season 2 of SERious Epidemiology, Hailey and Matt connect with Dr. Maya Mathur for a discussion on confounding. We talk about different ways of thinking about confounding and we discuss how different sources of bias can come together. We talk about overadjustment bias, a topic we all feel needs more attention. We discuss e-values, and have Dr. Mathur explain their practical utility and also how complicated they are to interpret. And we discuss bias analysis for meta-analyses.

Article mentioned in this episode:

Schisterman EF, Cole SR, Platt RW. Overadjustment bias and unnecessary adjustment in epidemiologic studies. Epidemiology. 2009 Jul;20(4):488-95. doi: 10.1097/EDE.0b013e3181a819a1. PMID: 19525685; PMCID: PMC2744485.

S2E15: As random as it gets

In this episode of Season 2 of SERious Epidemiology, Hailey and Matt finally start talking about random error. We explore the deep philosophical (as deep as we are capable of) meaning behind randomness and whether the universe is a random (and hey, while we are at it, is there even free will) and how we think about random error. We talk about p-hacking and p-curves and anything p really. And we talk about precision and accuracy in epidemiologic research. And Hailey aces Matt’s quiz.

S2E16: There’s a 95% probability you’ll enjoy learning about sample size and precision with Dr. Jon Huang

In this episode of Season 2 of SERious Epidemiology, Hailey and Matt connect with Dr. Jon Huang for a discussion on precision and study size. We wade into whether or not we should use p-values. We discuss whether the debates on p-values are real or just on Twitter and whether they should be used in observational epi or just in trials. We ask whether p-values do more harm than good in observational studies or whether the harm is really around null hypothesis significance testing. We talk about misconceptions about p-values. And Jon tells us how he’s going to win a gold medal in the Winter Olympics, despite living in a tropical climate.

S3E1: Are we measuring what we think we’re measuring?

In the season three premiere Matt and Hailey discuss Chapter 13 in Modern Epidemiology, 4th edition. For the third season of the SERious Epi podcast, we are going to continue our close-reading of the newest version of the Modern Epi textbook. This chapter is focused on measurement error and misclassification. In this episode we discuss issues related to the mis-measurement of exposure, outcome, and covariates. We also debate whether misclassification is just an analytic issue (i.e., putting people into the wrong categories) or an analytic + conceptual issue (i.e., putting people into the wrong categories and having an incorrect definition for those categories). We also talk about measurement error DAGs, why we wish more people use analytic approaches to correct for measurement error, and Matt explains the concept of email bankruptcy.

S3E2: Should we try to ensure misclassification is non-differential? Discussing measurement error with Dr. Patrick Bradshaw

In this episode we have a conversation with Patrick Bradshaw about issues related to measurement error, misclassification, and information bias. We ask him to help define and clarify the differences between these concepts. We chat about dependent and differential forms of misclassification and how helpful DAGs can be for identifying these sources of bias. Patrick helps to explain the problem with the over-reliance on non-differential bias producing a bias toward the null and concerns about being “anchored to the null” in epidemiologic analyses. This episode will also serve to provide you with the most up-to-date information from Patrick on his recommendations about excellent new TV shows to stream (Wednesday on Netflix; Wandavision on Disney+). Two thumbs up.

S3E3: How do we deal with the people who never made it into our study?

In this episode, Matt and Hailey discuss all things selection bias. This chapter on selection bias and generalizability is the shortest of the bias chapters in the Modern Epidemiology textbook. Does that mean it’s the simplest? Listen to this episode and decide for yourself!

S3E4: Selecting people or selecting data: exploring different aspects of selection bias

In this episode we feature a super expert on all things related to selection bias, Dr. Chanelle Howe. There are a lot of confusing issues related to selection bias: how it’s defined, how it relates to collider stratification bias, whether it’s a threat to internal or external validity (or both!). Chanelle helps us understand many of the nuances related to selection bias and provides helpful resources for readers interested in learning more about the topic. Is a lack of exchangeability related to confounding bias or selection? How can DAGs help us decipher the difference between confounding bias and selection? Can you have selection bias in a prospective cohort study? Join us to find out the answers to all of these questions and much more!

Resources:

Hernán MA. Invited Commentary: Selection Bias Without Colliders. Am J Epidemiol. 2017 Jun 1;185(11):1048-1050. doi: 10.1093/aje/kwx077. PMID: 28535177; PMCID: PMC6664806.

Lu H, Cole SR, Howe CJ, Westreich D. Toward a Clearer Definition of Selection Bias When Estimating Causal Effects. Epidemiology. 2022 Sep 1;33(5):699-706. doi: 10.1097/EDE.0000000000001516. Epub 2022 Jun 6. PMID: 35700187; PMCID: PMC9378569.

Howe CJ, Cole SR, Chmiel JS, Muñoz A. Limitation of inverse probability-of-censoring weights in estimating survival in the presence of strong selection bias. Am J Epidemiol. 2011 Mar 1;173(5):569-77. doi: 10.1093/aje/kwq385. Epub 2011 Feb 2. PMID: 21289029; PMCID: PMC3105434.

S3E5: Should I memorize the Mantel Haenszel formula?

This is an episode focused on ME4 Chapter 18 (Stratification and Standardization). This is a pretty formula-heavy chapter and I’m sure all of our listeners are tuning in to hear Matt’s voice read them to you: “The sum of M1i times T0i….”. So sorry to disappoint, but instead, we focused this issue on big picture conceptual issues discussed in the chapter. Matt and Hailey talk about the importance of stratification, compare pooling and standardization, discuss Mantel Haenszel and maximum likelihood estimation, and then finish the episode talking about homogeneity and heterogeneity.

S3E6: Stratification with Rich MacLehose: Should you have Bert or Ernie pick you up from surgery?

In this episode we discuss Chapter 18 in the Modern Epidemiology (4th Ed) textbook focused on stratification and standardization with Dr. Rich MacLehose. We invited the illustrious Dr. MacLehose to be the guest for this chapter because it is one of the most important in the book, linking the theoretical concepts discussed in the early chapters with the advanced analytic techniques discussed in subsequent chapters. In this episode we cover topics such as standardization, stratification, pooling, the use and interpretation of relative and absolute effect estimates, and p-values to evaluate effect heterogeneity.

S3E7: Are time to event analyses the Space Mountain of epidemiology?

In this episode Matt and Hailey discuss Chapter 22 of the 4th edition of Modern Epidemiology. This is a chapter focused on time to event analyses including core concepts related to time scales, censoring, and understanding rates. We discuss the issues and challenges related to time to event analyses and analytic approaches in this setting including Kaplan Meier, Cox Proportional Hazards, and other types of fancy models that are frequently taught in advanced epi courses (e.g., Weibull, Accelerated Failure Time) but infrequently used in the real-world. The chapter ends with a brief discussion of competing risks. It’s clear that Matt and Hailey need to brush up on concepts related to competing risks and semi-competing risks, and fortunately next month we’ll have an expert join us to answer all of our questions!

S3E8: Maybe censoring is the least of your worries?

Recording from across the globe, in Melbourne, Australia, Dr. Margarita Moreno-Betancur joins us for an episode on Chapter 22 in Modern Epidemiology (4th edition) on Time-to-Event Analyses. This is a chapter focused on the methods we use when the timing of the occurrence of the event is of central importance. Dr. Moreno-Betancur answers all our questions about these types of analyses, including: the importance of the time scale, defining the origin (time zero), censoring vs. truncation. We also ask Dr. Moreno-Betancur to weigh-in on a hot take about whether the Cox Proportional Hazard model is overused in the health sciences literature.

S3E9: Feedback loops? Feedback spirals? Disentangling what we know about time-varying exposures.

This episode is focused on Chapter 25 of Modern Epidemiology 4th edition, Causal Inference with Time Varying Exposures. In this episode, Matt and Hailey talk about how we should think about exposures that change over time. We discuss the concept of feedback loops- scenarios where the exposure affects outcome which affects a later time point of exposure and then that exposure affects a later outcome. We think about whether biologic (mechanistic) conceptualizations of feedback loop the same as the epidemiologic notion presented in the chapter. We then follow the chapter to continue our discussion about how time varying exposures change our frameworks for thinking about causal inference and analytic strategies (e.g., marginal structural models, g-formula, and structural mean models).

A historical note about Andrew James Rhodes, whose picture is hanging up in the conference room that Hailey was recording from.

S3E10: Time-varying everything everywhere all at once

In this episode, we are joined by Dr. Sonia Hernandez Diaz for a discussion on Chapter 25 in Modern Epidemiology, 4th edition. This chapter is focused on methods for causal inference in longitudinal settings, with a particular focus on time varying exposures. Dr. Hernandez-Diaz helps to explain some of the conceptual and methodological challenges related to time-varying exposures, including the advanced analytic strategies required and the careful conceptual considerations about defining the exposure of interest and causal questions.

Papers referenced in this episode:

S3E11: You say tomato, I say tom-ah-to: a (somewhat) head-spinning discussion about interaction analyses

Matt and Hailey take a deep dive into Chapter 26 in Modern Epidemiology, 4th Edition, Analysis of Interaction. This episode needs a content warning- it is among the most advanced and conceptually complex topics we have ever covered on SERious Epi. Interaction occurs when the effect of one exposure on outcome depends in some way on the presence or absence of another exposure. Seems like a simple enough concept, right? However, as you’ll see in this episode, there are many different layers of complexity to consider related to terminology, scale, and interpretation of interaction analyses. 

A note from Matt and Hailey: since this material is very complex, we reached out to Dr. Jay Kaufman for his perspective on the episode before releasing it. He had some very helpful thoughts, and we would like to share them with you (paraphrasing with his permission): 

Part of what is confusing about this topic is the terminology differences, with Hailey using terminology (“interaction”) that lines up with that used by VanderWeele, ME4, and the Hernán and Robins textbook chapter and Matt using terminology (“interdependence”) from other articles in the literature, such as Greenland and Poole (1988). When there are joint effects that are exactly multiplicative, or supermultiplicative, you know it’s a causal interaction (i.e., synergistic or biologic interaction) because multiplicativity is necessarily super-additive as long as both exposures meet consistency, exchangeability, and positivity assumptions. However, knowing that joint effects are submultiplicative  is not informative about additive interaction or synergism. It is also not possible to make a conclusion about additive interaction when a results section tells you only that in a logistic or Cox regression analysis there is “no significant interaction effect (p<0.05)” as that just tells you an effect is not exactly multiplicative. Multiplicativity has some causal implications because it is super additive as long as the causal assumptions listed above are plausibly satisfied. There are several proposed causal mechanisms that would generate multiplicative joint effects especially from the cancer epidemiology literature (e.g., Koopman 1990). In general,  considering interaction on the additive scale is more useful for assessing public health relevance (e.g. Panagiotou and Wacholder 2014).

Some of these concepts are difficult to convey in podcast format, so we’re including some helpful resources for anyone interested in learning more about this topic. Thanks again to Dr. Kaufman for helping us put this list together:

  • Greenland S, Poole C. Invariants and noninvariants in the concept of interdependent effects. Scand J Work Environ Health. 1988 Apr;14(2):125-9. doi: 10.5271/sjweh.1945. PMID: 3387960.
  • VanderWeele TJ. On the distinction between interaction and effect modification. Epidemiology. 2009 Nov;20(6):863-71. doi:  10.1097/ EDE.0b013e3181ba333c.
  • VanderWeele TJ. The Interaction Continuum. Epidemiology. 2019 Sep;30(5):648-658. doi:  10.1097/ EDE.0000000000001054. PMID: 31205287; PMCID: PMC6677614.
  • Greenland S, Poole C. Invariants and noninvariants in the concept of interdependent effects. Scand J Work Environ Health. 1988 Apr;14(2):125-9. doi: 10.5271/ sjweh.1945. PMID: 3387960.
  • Koopman JS, Weed DL. Epigenesis theory: a mathematical model relating causal concepts of pathogenesis in individuals to disease patterns in populations. Am J Epidemiol. 1990 Aug;132(2):366-90. doi: 10.1093/ oxfordjournals.aje.a115666. PMID: 2372013.
  • Panagiotou OA, Wacholder S. Invited commentary: How big is that interaction (in my community)–and in which direction? Am J Epidemiol. 2014 Dec 15;180(12):1150-8. PMID: 25395027.

S3E12: Start with the questions that are easy to answer and then move on to the more challenging questions

It’s hard to believe this is the final episode of season 3! In this season finale episode, we continue our discussion of topics related to Chapter 26 in Modern Epidemiology (4th Edition) with Dr. Eric Tchetgen Tchetgen. In this conversation we ask Dr. Tchetgen Tchetgen to help us better understand several issues related to interaction, including why it’s so important to study interaction.  He provides a helpful framework for thinking about interaction: start simple and then move on to more complex questions. As part of this framework, he emphasizes the distinction between total effects and main effects, how confounding plays into conversations about interaction, and the role of scale dependence when interpretating interaction.

produced by the Society for Epidemiologic Research

Interested in learning more about SERious EPI, feel free to reach out to me directly